ASHLEY DUKE: Open Payments
NPI 1467894279 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$685 in 31 payments from 12 companies in 2025. Trend: 2023 $886 · 2024 $1,224 · 2025 $685
Food & beverage: $675Education: $10
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $225 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $136 |
| Novo Nordisk Inc | 4 | $84 |
| PFIZER INC. | 3 | $48 |
| Phathom Pharmaceuticals, Inc. | 3 | $36 |
| Dexcom, Inc. | 1 | $34 |
| SANOFI PASTEUR INC. | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $27 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Exact Sciences Corporation | 1 | $17 |
Products named: AIRSUPRA, JARDIANCE, Ozempic, VOQUEZNA, Dexcom G6 Transmitter, ELIQUIS, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, CAPLYTA.
Industry payments across FL — which companies pay providers there.
